Annual FCF
-$81.17 M
-$51.95 M-177.79%
31 December 2023
Summary:
Mineralys Therapeutics annual free cash flow is currently -$81.17 million, with the most recent change of -$51.95 million (-177.79%) on 31 December 2023. During the last 3 years, it has fallen by -$66.61 million (-457.55%). MLYS annual FCF is now -3195.70% below its all-time high of -$2.46 million, reached on 01 December 2020.MLYS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$50.22 M
-$20.08 M-66.60%
30 September 2024
Summary:
Mineralys Therapeutics quarterly free cash flow is currently -$50.22 million, with the most recent change of -$20.08 million (-66.60%) on 30 September 2024. Over the past year, it has dropped by -$21.24 million (-73.30%). MLYS quarterly FCF is now -818.32% below its all-time high of -$5.47 million, reached on 01 June 2022.MLYS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$128.55 M
-$31.19 M-32.04%
30 September 2024
Summary:
Mineralys Therapeutics TTM free cash flow is currently -$128.55 million, with the most recent change of -$31.19 million (-32.04%) on 30 September 2024. Over the past year, it has dropped by -$47.38 million (-58.36%). MLYS TTM FCF is now -1854.21% below its all-time high of -$6.58 million, reached on 01 March 2022.MLYS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLYS Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -73.3% | -58.4% |
| 3 y3 years | -457.6% | - | - |
| 5 y5 years | - | - | - |
MLYS Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -457.6% | at low | -818.3% | at low | -1854.2% | at low |
| 5 y | 5 years | -3195.7% | at low | -818.3% | at low | -1854.2% | at low |
| alltime | all time | -3195.7% | at low | -818.3% | at low | -1854.2% | at low |
Mineralys Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$50.22 M(+66.6%) | -$128.55 M(+32.0%) |
| June 2024 | - | -$30.15 M(+57.0%) | -$97.36 M(+11.1%) |
| Mar 2024 | - | -$19.20 M(-33.8%) | -$87.60 M(+7.9%) |
| Dec 2023 | -$81.17 M | -$28.98 M(+52.3%) | -$81.17 M(+30.1%) |
| Sept 2023 | - | -$19.03 M(-6.6%) | -$62.38 M(+23.9%) |
| June 2023 | - | -$20.39 M(+59.6%) | -$50.34 M(+42.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.78 M(+25.4%) | -$35.42 M(+21.2%) |
| Dec 2022 | -$29.22 M(+100.7%) | -$10.19 M(+45.8%) | -$29.22 M(+53.5%) |
| Sept 2022 | - | -$6.99 M(+27.8%) | -$19.04 M(+58.0%) |
| June 2022 | - | -$5.47 M(-16.9%) | -$12.05 M(+83.1%) |
| Mar 2022 | - | -$6.58 M | -$6.58 M |
| Dec 2021 | -$14.56 M(+491.1%) | - | - |
| Dec 2020 | -$2.46 M | - | - |
FAQ
- What is Mineralys Therapeutics annual free cash flow?
- What is the all time high annual FCF for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly FCF year-on-year change?
- What is Mineralys Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Mineralys Therapeutics?
- What is Mineralys Therapeutics TTM FCF year-on-year change?
What is Mineralys Therapeutics annual free cash flow?
The current annual FCF of MLYS is -$81.17 M
What is the all time high annual FCF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual free cash flow is -$2.46 M
What is Mineralys Therapeutics quarterly free cash flow?
The current quarterly FCF of MLYS is -$50.22 M
What is the all time high quarterly FCF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly free cash flow is -$5.47 M
What is Mineralys Therapeutics quarterly FCF year-on-year change?
Over the past year, MLYS quarterly free cash flow has changed by -$21.24 M (-73.30%)
What is Mineralys Therapeutics TTM free cash flow?
The current TTM FCF of MLYS is -$128.55 M
What is the all time high TTM FCF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high TTM free cash flow is -$6.58 M
What is Mineralys Therapeutics TTM FCF year-on-year change?
Over the past year, MLYS TTM free cash flow has changed by -$47.38 M (-58.36%)